Newspaper Publication of Unaudited Financial Results for the period ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Star Source Multi Trade Ltd (formerly Chemo Pharm Laboratories Ltd) submitted copies of its newspaper advertisement of unaudited financial results for the quarter and half year ended September 30, 2025, as required under Regulation 47 of SEBI's Listing Regulations, 2015. The results were published in Business Standard and Mumbai Lakshdeep on November 14, 2025. Per the published extract, total income from operations for Q2 FY26 stood at Rs. 5,255.56 thousand versus Rs. 6,310.00 thousand in Q2 FY25. Net profit before tax for the quarter was Rs. 980.14 thousand, compared to a loss in the year-ago quarter, suggesting a sequential recovery in profitability. The signed filing was submitted by Ruchit Mehta, Managing Director & CEO.
This is a routine regulatory disclosure confirming newspaper publication of quarterly results, not a material corporate action. Shareholders can access the detailed financial results on the BSE website and the company's website for deeper analysis, but no immediate share-price catalyst is implied.